# A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors

> **NCT07068932** · PHASE1 · RECRUITING · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 102 (estimated)

## Conditions studied

- Malignant Tumors of Adults

## Interventions

- **DRUG:** SHR-4506 Injection

## Key facts

- **NCT ID:** NCT07068932
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-22
- **Primary completion:** 2027-02
- **Final completion:** 2027-08
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07068932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07068932, "A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT07068932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*